Clinical Trial

Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH

Name: Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH — clinical trial record (NCT07187193)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Treatment of Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis (LCH) Using a Low-Dose Cytarabine Combined with Thalidomide Regimen.

Trial Details

NCT Number	NCT07187193
Lead Sponsor	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions	Langerhans Cell Histiocytosis
Enrollment	50 participants
Start Date	2025-04-12
Primary Completion	2027-04-12 (estimated)
Study Completion	2027-04-13 (estimated)
Updated on ClinicalTrials.gov	2025-09-22